Wang Xu-Mei, Ye Yun-Hua, Tu Zong-Cai, Hu Yue-Ming, Wang Hui, Huang Tao
State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang, Jiangxi 330047, People's Republic of China.
National R&D Center of Freshwater Fish Processing, Jiangxi Normal University, Nanchang, Jiangxi 330022, People's Republic of China.
J Agric Food Chem. 2021 Mar 31;69(12):3741-3750. doi: 10.1021/acs.jafc.1c00205. Epub 2021 Mar 19.
Glycation between proteins and reducing sugars is the common chemical modification in food protein, and many studies have focused on the allergenicity of the glycated protein. However, a systemic study on the allergenicity change of its digests is lacking. In this work, we explored the change rule of the digestibility and allergenicity of glycated β-Lg during gastrointestinal digestion and interpreted the mechanism using high-resolution mass spectrometry. Glycation with arabinose increased the resistance of β-Lg to digestive enzyme, with a low hydrolysis value. Indirect competitive ELISA showed that the IgG/IgE binding rates of β-Lg were reduced after glycation and further reduced after digestion, in comparison with the digests of unglycated β-Lg. There are two reasons for this phenomenon. On the one hand, 11 glycated sites were determined in the lowest allergenicity arabinose-β-Lg conjugation (Ara-β-Lg), which was distributed in the IgG and IgE linear allergic epitopes of β-Lg. On the other hand, glycation masking linear allergenic epitopes had a more significant effect on reducing allergenicity in comparison to digestive enzyme hydrolysis. These results indicated that the allergenicity of Ara-β-Lg in the human body might be lower than that of unglycated β-Lg.
蛋白质与还原糖之间的糖基化反应是食品蛋白质中常见的化学修饰,许多研究都聚焦于糖基化蛋白质的致敏性。然而,目前缺乏对其消化产物致敏性变化的系统性研究。在本研究中,我们探究了糖基化β-乳球蛋白在胃肠道消化过程中消化率和致敏性的变化规律,并利用高分辨率质谱对其机制进行了解析。与阿拉伯糖发生糖基化反应增加了β-乳球蛋白对消化酶的抗性,水解值较低。间接竞争ELISA结果表明,与未糖基化β-乳球蛋白的消化产物相比,糖基化β-乳球蛋白的IgG/IgE结合率在糖基化后降低,消化后进一步降低。出现这种现象有两个原因。一方面,在致敏性最低的阿拉伯糖-β-乳球蛋白缀合物(Ara-β-Lg)中确定了11个糖基化位点,这些位点分布在β-乳球蛋白的IgG和IgE线性过敏表位中。另一方面,与消化酶水解相比,糖基化掩盖线性过敏表位对降低致敏性的影响更为显著。这些结果表明,Ara-β-Lg在人体内的致敏性可能低于未糖基化的β-乳球蛋白。